Medical Mycology – Page 2

Closing the diagnostic gap in medical mycology: The LODDY Test for identification of Lodderomyces elongisporus

mycolabadmin

Researchers developed a simple and affordable test called the LODDY Test to identify a dangerous yeast called Lodderomyces elongisporus that is often mistaken for a similar but less dangerous yeast. This test uses color changes on a special culture medium to distinguish between different yeast species in just 48 hours without expensive equipment. The test works perfectly in laboratories worldwide and could help doctors in developing countries diagnose and treat serious fungal infections more quickly and accurately.

MycoNews 2023: Editorial, news, reports, awards, personalia, and book news

mycolabadmin

This report highlights major developments in mycology during 2023, featuring updates from international fungal research conferences held around the world. It covers new awards recognizing fungal research including innovative uses of fungi for environmental cleanup and sustainable energy storage. The report also discusses emerging therapeutic uses of psilocybin-containing mushrooms for treating depression and anxiety, and emphasizes the importance of international gatherings for mycologists to share discoveries and collaborate.

New Strategies to Combat Human Fungal Infections

mycolabadmin

Fungal infections are becoming a major global health threat, causing millions of deaths annually. This research collection presents new and improved ways to treat these infections, including natural compounds like chitosan, beneficial bacteria, new drug combinations, and tests to better understand which treatments work best. The papers showcase innovative approaches beyond traditional antifungal medications to help combat resistant infections.

Key Fungal Secreted Proteases in Coccidioidomycosis

mycolabadmin

Researchers studied how a dangerous fungus called Coccidioides causes disease by examining special proteins called proteases that the fungus secretes. They found that blocking these proteases prevented the fungus from forming the spherule structures that allow it to spread inside infected people. This discovery could lead to new treatments for coccidioidomycosis, a serious infection that affects people in the Southwest United States.

Aspartyl protease MfSAP2 is a key virulence factor in mycelial form of skin fungi Malassezia furfur

mycolabadmin

Malassezia furfur is a common skin fungus that can change from round yeast cells to thread-like filaments. When it becomes thread-like, it produces a special enzyme called MfSAP2 that damages the proteins holding together the dead skin cells that form our skin’s protective barrier. This damage may be responsible for the patches and discoloration seen in pityriasis versicolor, a common skin condition.

Madurella tropicana and Madurella pseudomycetomatis identified as new causative agents of black grain eumycetoma in Senegal

mycolabadmin

This case report describes two patients in Senegal with a serious fungal infection called eumycetoma caused by previously unidentified fungal species. Using modern DNA sequencing methods, researchers identified the infections as being caused by Madurella tropicana and Madurella pseudomycetomatis, rather than the previously known Madurella mycetomatis. One patient treated with the antifungal drug itraconazole showed good improvement, highlighting the importance of accurate identification for proper treatment.

Occurrence of Pathogenic and Allergenic Molds in the Outdoor and Indoor Environment of a Major Hospital and Molecular Epidemiology of Aspergillus fumigatus in Kuwait

mycolabadmin

Researchers studied molds found in and around a major hospital in Kuwait over 17 months, collecting over 6,000 mold samples. They discovered various mold species, including some that can cause serious infections in hospital patients. Importantly, they found drug-resistant Aspergillus fumigatus strains both outdoors and inside the hospital, suggesting the environment may be a source of infection for vulnerable patients. The findings highlight the need for better monitoring and control of molds in hospital settings.

Drug repurposing to fight resistant fungal species: Recent developments as novel therapeutic strategies

mycolabadmin

Fungal infections are becoming increasingly difficult to treat due to growing drug resistance, affecting millions of people worldwide each year. This research collection explores creative solutions by repurposing existing medications and developing new combination therapies that work better together against resistant fungal species. Studies show promising results combining common antibiotics like minocycline with antifungal drugs, and natural compounds from traditional medicine show potential for treating hard-to-treat infections like Candida and Aspergillus.

First occurrence of feline sporotrichosis in a metropolitan area of Central-West Brazil

mycolabadmin

Researchers in Brazil discovered the first case of a serious fungal infection called sporotrichosis in a domestic cat in the Goiania metropolitan area. The infection was caused by a fungus called Sporothrix brasiliensis, which can spread from cats to humans through scratches and bites. This finding is important because it shows the disease is spreading to new regions of Brazil that previously didn’t have confirmed cases, and suggests residents need to be cautious around stray cats.

Spread of Antifungal-Resistant Trichophyton indotineae, United Kingdom, 2017–2024

mycolabadmin

A fungal infection called Trichophyton indotineae, which originated in Asia, is rapidly spreading throughout the United Kingdom and becoming resistant to common antifungal treatments. The infection typically starts in the groin area and can spread to other parts of the body, and many cases fail to respond to standard antifungal drugs like terbinafine. Researchers tracked 157 cases over seven years and found the fungus now accounts for over a third of all dermatophyte infections sent to the UK reference laboratory. Doctors and laboratory professionals are being urged to recognize this emerging threat and consider better diagnostic and treatment strategies.

Research Topic: Medical Mycology